Quality of Life and Lung Function on Post Covid-19 Patient

COVID-19 Clinical Trial

— Covid-19  

Official title:

Effect of Breathing Exercise on Chest Expansion, Quality of Life and Lung Function on Post Covid-19 Patient: A Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05172102
• Other study ID #: H-04-Q-001
• Status: Completed
• Phase: N/A
• Start date: December 20, 2021
• Est. completion date: March 30, 2023

Study information

• Verified date: April 2023
• Source: Qassim University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Gaining a greater understanding of how the breathing exercise combined with aerobic and strengthening exercises will affects lung function and quality of life in post covid-19 persons

Description:

this will improve exercise prescription guidelines relevant to this post covid-19. Therefore, the purpose of this work was determining the effect of breathing exercise combined with aerobic and strengthening exercises in improve chest expansion, lung function and quality of life in post covid-19 persons.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: March 30, 2023
• Est. primary completion date: March 20, 2023
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 20 Years to 30 Years

Eligibility

Inclusion Criteria:

• Female. Age from 20 to 30 years old. - Body mass index (BMI) 19 to 24 kg/m2.- Non-smoker- Recovered from COVID-19 over the past 12 months. - They are experiencing mild to moderate symptoms without any complications. -
• Able to use online communication programs.

Exclusion Criteria:

• - Anyone who does regular physical exercise.
• history of acute illness, asthma, pulmonary fibrosis, hypertension, diabetes disease.
• hypoxemia in rest.

Related Conditions & MeSH terms

• COVID-19

Intervention

Other:
• breathing exercise, Aerobic exercises
6 min of quiet breathing (3 sets of 2 min each), 6 min of diaphragmatic breathing (3 sets of 2 min each), 6 min of diaphragmatic breathing plus pursed-lips breathing (3 sets of 2 min each).

Locations

Country	Name	City	State
Saudi Arabia	College of medical rehabilitation	Buraidah	Qassim

Sponsors (1)

Lead Sponsor	Collaborator
Qassim University

Country where clinical trial is conducted

Saudi Arabia, 

References & Publications (3)

Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther Clin Pract. 2020 May;39:101166. doi: 10.1016/j.ctcp.2020.101166. Epub 2020 Apr 1. — View Citation

Mendes LP, Moraes KS, Hoffman M, Vieira DS, Ribeiro-Samora GA, Lage SM, Britto RR, Parreira VF. Effects of Diaphragmatic Breathing With and Without Pursed-Lips Breathing in Subjects With COPD. Respir Care. 2019 Feb;64(2):136-144. doi: 10.4187/respcare.063 — View Citation

Ubolnuar N, Tantisuwat A, Thaveeratitham P, Lertmaharit S, Kruapanich C, Mathiyakom W. Effects of Breathing Exercises in Patients With Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis. Ann Rehabil Med. 2019 Aug;43(4):509-523. doi — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Health-related quality of life, Medical Outcomes Study short-form (SF-36)	assessed using the Short Form-36 (SF-36). The SF-36 scale had 8 dimensions, and each dimension was converted into a percentage score.	at baseline
Primary	Health-related quality of life, Medical Outcomes Study short-form (SF-36)	assessed using the Short Form-36 (SF-36). The SF-36 scale had 8 dimensions, and each dimension was converted into a percentage score.	after 6 weeks
Primary	Respiratory function measurement	assessed by a spirometer. The following parameters related to respiratory function will be measured: (1) forced expiratory volume in 1 second (FEV1); (2) forced vital capacity (FVC).	at baseline
Primary	Respiratory function measurement	assessed by a spirometer. The following parameters related to respiratory function will be measured: (1) forced expiratory volume in 1 second (FEV1); (2) forced vital capacity (FVC).	after 6 weeks
Secondary	Chest expansion measurement	measured with a tape measure at 2 different levels of the rib cage. Measurements will be taken at the maximal inspiration and expiration	at baseline
Secondary	Chest expansion measurement	measured with a tape measure at 2 different levels of the rib cage. Measurements will be taken at the maximal inspiration and expiration	after 6 weeks
Secondary	Exercise endurance measurement	measured by the 6-min walk test (6MWT), is the distance one walks within 6 min	at baseline
Secondary	Exercise endurance measurement	measured by the 6-min walk test (6MWT), is the distance one walks within 6 min	after 6 weeks